Trial Profile
S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 22 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrilals.gov.
- 20 May 2013 New trial record